Endurance Wipe

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for reducing oversensitivity in males in advance of intercourse.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals should instruct patients to apply a small amount of the product to the shaft of the penis prior to intercourse, or as directed by a physician. It is important to ensure that the product is thoroughly washed off after intercourse to maintain proper hygiene and avoid any potential irritation.

Contraindications

Use is contraindicated in patients who have ingested the product. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is required.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to avoid contact with the eyes during application.

Patients should be instructed to discontinue use and seek medical attention under the following circumstances: if the product does not provide relief when used as directed, as this may indicate an underlying condition that requires medical evaluation; if either the patient or their partner experiences a rash or irritation, including symptoms such as burning or itching; or if symptoms persist despite use.

In the event of accidental ingestion, it is imperative to seek medical assistance or contact a Poison Control Center immediately.

Side Effects

Patients using this product should be aware that it is intended for external use only. Care should be taken to avoid contact with the eyes, as this may lead to irritation or other adverse effects.

In clinical practice, patients are advised to discontinue use and seek medical attention if the product does not provide relief as directed. It is important to note that premature ejaculation may be indicative of an underlying condition that requires medical supervision. Additionally, if either the patient or their partner experiences a rash or irritation, such as burning or itching, they should stop using the product and consult a healthcare professional. Persistent symptoms should also prompt a medical evaluation to rule out any serious underlying issues.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Endurance Wipe (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, it is crucial to seek medical assistance or contact a Poison Control Center immediately.

Geriatric Use

There is no specific information regarding the use of PROMESCENT® endurance wipes in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when considering the use of this product in elderly patients, as the absence of data necessitates careful monitoring and individualized assessment of treatment risks and benefits.

Pregnancy

The safety of this product during pregnancy has not been established. It is not recommended for use during pregnancy due to potential risks to the fetus. Pregnant patients or those planning to become pregnant should consult a healthcare provider before using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise caution and consider the lack of data when prescribing this medication to patients with liver problems.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary significantly depending on the substance involved and the individual patient’s characteristics. Symptoms may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of suspected overdosage, immediate assessment of the patient's condition is crucial. Recommended actions include:

1. Assessment: Conduct a thorough evaluation of the patient's vital signs and clinical status.

2. Supportive Care: Initiate supportive measures as necessary, including airway management, oxygen supplementation, and intravenous fluids.

3. Decontamination: If appropriate and within a reasonable timeframe, consider gastrointestinal decontamination methods such as activated charcoal, provided the patient is alert and able to protect their airway.

4. Specific Antidotes: If a specific antidote is available for the substance involved, it should be administered according to established protocols.

Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance on management strategies tailored to the specific circumstances of the overdose. Continuous monitoring and supportive care are paramount until the patient stabilizes or further interventions are deemed necessary.

Documentation of the incident, including the substance involved, estimated dose, time of ingestion, and any interventions performed, is critical for ongoing patient management and future reference.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Serious adverse effects associated with this product have been reported through voluntary reporting and surveillance programs. Healthcare professionals and patients are encouraged to report any serious adverse events to the designated contact number, 1-877-852-0106.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in its original packaging, which should be retained to ensure access to complete product information. It is essential to store the product at room temperature and to avoid freezing. Additionally, the product must be kept out of reach of children to ensure safety. Users are advised not to flush the wipes to prevent plumbing issues.

Additional Clinical Information

Patients should apply a small amount of the product to the head shaft of the penis before intercourse, or as directed by a clinician, and wash it off after intercourse. It is important to avoid contact with the eyes during use. Patients are advised to discontinue use and consult a doctor if the product does not provide relief as directed, as premature ejaculation may indicate an underlying condition that requires medical attention. Additionally, if either the patient or their partner experiences a rash or irritation, such as burning or itching, they should seek medical advice if symptoms persist.

For reporting serious adverse effects associated with this product, patients or healthcare providers can call 1-877-852-0106.

Drug Information (PDF)

This file contains official product information for Endurance Wipe, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)